ArticleAfrican journal of laboratory medicine2018
Leveraging donor support to develop a national antimicrobial resistance policy and action plan: Ghana's success story.
Article in African journal of laboratory medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed.
- Exploring the Current Situation and Developing Strategies for Behavior Change to Improve Antibiotic Use in West Africa: Protocol for a Multidisciplinary Interventional Research Project.JMIR research protocols · 2025Article
- Mapping antibiotic resistance in Ghana: a narrative review of regional variations in antibiotic-resistant ESKAPEE pathogens.Frontiers in microbiology · 2025Review
- Article
- Fighting Antimicrobial Resistance: Development and Implementation of the Ghanaian National Action Plan (2017-2021).Antibiotics (Basel, Switzerland) · 2022Article
- International Travel as a Risk Factor for Carriage of Extended-Spectrum β-Lactamase-ProducingInternational journal of environmental research and public health · 2022Article
- Antimicrobial resistance national level dialogue and action in Ghana: setting and sustaining the agenda and outcomes.One health outlook · 2021Article
- Antimicrobial use in hospitalized patients: a multicentre point prevalence survey across seven hospitals in Ghana.JAC-antimicrobial resistance · 2021Article
- The Governance and Implementation of the National Action Plan on Antimicrobial Resistance in Tanzania: A Qualitative Study.Antibiotics (Basel, Switzerland) · 2021Article
- Leapfrogging laboratories: the promise and pitfalls of high-tech solutions for antimicrobial resistance surveillance in low-income settings.BMJ global health · 2020Review
- Benchmarking national action plans on antimicrobial resistance in eight selected LMICs: Focus on the veterinary sector strategies.Journal of global health · 2020Article
- Antimicrobial resistance surveillance in Africa: Successes, gaps and a roadmap for the future.African journal of laboratory medicine · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTo mitigate the increasing trend of antimicrobial drug resistance (AMR), the Global Action Plan (GAP) on AMR was adopted at the 68th World Health Assembly in May 2015. Subsequently, member countries were encouraged to mirror the five key strategic objectives of GAP to develop their respective National Action Plans (NAPs) by 2017. Country-specific data on AMR is, however, critical for a comprehensive NAP that will inform policy and also anchor all the objectives of GAP. Systematic reviews have been suggested by some authors to generate relevant data to inform NAP development.
objectivesThis article highlights Ghana's success story in the development of its AMR policy documents and how it could further be implemented through donor support.
methodsLiterature and desk review of the activities of Ghana's National Platform on Antimicrobial Resistance leading to the development of the NAP and AMR policy was done.
resultsGhana launched its NAP together with the accompanying policy document in April 2018. Country-specific data, which guided these documents, were obtained by leveraging donor support activities through the National Platform on Antimicrobial Resistance.
conclusionGhana's success story on the development of AMR policy documents is pivoted on a strong political will and the leveraging of donor support for specific activities.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.